UNIGENE LABORATORIES INC - FORM 10-K - EX-23.2 - CONSENT OF ERNST & YOUNG LLP - March 16, 2010

Attached files

file filename
10-K - UNIGENE LABORATORIES, INC. - UNIGENE LABORATORIES INCd10k.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - UNIGENE LABORATORIES INCdex231.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - UNIGENE LABORATORIES INCdex321.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - UNIGENE LABORATORIES INCdex322.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - UNIGENE LABORATORIES INCdex311.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - UNIGENE LABORATORIES INCdex312.htm
EX-10.70 - COLLATERAL ASSIGNMENT AGREEMENT - UNIGENE LABORATORIES INCdex1070.htm
EX-10.67 - LICENSE AGREEMENT - UNIGENE LABORATORIES INCdex1067.htm
EX-10.71 - WARRANT EXCHANGE AGREEMENT - UNIGENE LABORATORIES INCdex1071.htm
EX-10.64 - ASSIGNMENT AND ASSUMPTION AGREEMENT - UNIGENE LABORATORIES INCdex1064.htm
EX-10.69 - OMNIBUS AMENDMENT AGREEMENT - UNIGENE LABORATORIES INCdex1069.htm
EX-10.68 - AMENDMENT TO LICENSE AGREEMENT - UNIGENE LABORATORIES INCdex1068.htm
EX-10.56 - ASSIGNMENT OF MORTGAGE - UNIGENE LABORATORIES INCdex1056.htm
EX-10.11 - FORM OF RESTRICTED AGREEMENT - UNIGENE LABORATORIES INCdex1011.htm

Exhibit 23.2

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated March 8, 2010, with respect to the financial statements of Tarsa Therapeutics, Inc. for the period from March 13, 2009 (date of inception) to December 31, 2009 in the Annual Report on Form 10-K of Unigene Laboratories, Inc. for the year ended December 31, 2009.

We also consent to the incorporation by reference in the following Registration Statements of Unigene Laboratories, Inc.:

 

  (1) Registration Statement (Form S-8 No. 333-01897)

 

  (2) Registration Statement (Form S-8 No. 333-35951)

 

  (3) Registration Statement (Form S-8 No. 333-52376)

 

  (4) Registration Statement (Form S-8 No. 333-85524)

 

  (5) Registration Statement (Form S-8 No. 333-137682)

 

  (6) Registration Statement (Form S-8 No. 333-161364)

 

  (7) Registration Statement (Form S-3 No. 333-124301)

 

  (8) Registration Statement (Form S-3 No. 333-133313)

 

  (9) Registration Statement (Form S-3 No. 333-163989)

 

  (10) Registration Statement (Form S-2 No. 333-109655)

of our report dated March 8, 2010, with respect to the financial statements of Tarsa Therapeutics, Inc. for the period from March 13, 2009 (date of inception) to December 31, 2009, included in this Annual Report on Form 10-K of Unigene Laboratories, Inc. for the year ended December 31, 2009.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania

March 15, 2010

Stock widget

Investing forum

UNIGENE LABORATORIES INC Reports

Also read